Product
Pv-R-CYM 1 and 2 Group B
1 clinical trial
2 indications
Indication
Non-Hodgkin LymphomaIndication
Hodgkin lymphomaClinical trial
Reducing the Burden of Oncologic Chemoradiotherapy And Radiation Exposure From Diagnostic Imaging by Utilizing Targeted Immunotherapy in Children, Adolescents and Young Adults With LymphomaStatus: Recruiting, Estimated PCD: 2027-12-31